Gül, Azra
van Geest, Sarita
Kuijper, Barbara
van der Plas, Anton Adriaan
Steyerberg, Ewout
Vleggeert-Lankamp, Carmen
Article History
Received: 28 October 2024
Revised: 27 May 2025
Accepted: 6 June 2025
First Online: 18 June 2025
Declarations
:
: The intended study is covered by the CASINO-trial protocol, which was approved by the Central Medical Ethics Committee Leiden (“Commissie Medische Ethiek Leiden University Medical Center,”) and the board of directors of the Spaarne Hospital Haarlem/Hoofddorp, Rijnland hospital Leiderdorp, Diaconessenhuis Leiden, Haaglanden Medical Center and Antoniushove the Hague. Written informed consent was obtained from all patients. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article. The study was registered July 3, 2012 in the Netherlands, Dutch Trial Register Number: NTR1289.
: The authors have no personal, financial, or institutional interest in any of the materials of devices described in this article.
: The authors declare no competing interests.